## Note
nid: 1472487655906
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Pharmacology, #AK_Step1_v11::#B&B::05_Cardio::06_Heart_Failure::04_Acute_Heart_Failure, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors::PDE_3_Inhibitors, #AK_Step1_v11::#FirstAid::05_Pharmacology::02_Autonomic_Drugs::15_Phosphodiesterase_Inhibitors::PDE_3_Inhibitors::Milrinone_Inamrinone, #AK_Step1_v11::#FirstAid::07_Cardiovascular::05_Pharm::11_Cardiac_Glycosides, #AK_Step1_v11::#FirstAid::07_Cardiovascular::05_Pharm::11_Cardiac_Glycosides::Milrinone_Inamrinone, #AK_Step1_v11::#OME_banner::Clinical::01_Cardiology::02_Heart_Failure, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::07_Milrinone, #AK_Step1_v11::#Physeo::09_Pharm::10_Cardiac::16_Digoxin, #AK_Step1_v11::#Pixorize::03_Pharm::06_Cardio::Milrinone, #AK_Step1_v11::#SketchyPharm::02_Cardio_&_Renal::01_Heart_Failure_Drugs::01_Digoxin,_milrinone,_nesiritide, #AK_Step1_v11::#UWorld::100-999::100-199::149, #AK_Step1_v11::^Other::^HighYield::1-HighYield, #AK_Step1_v11::^Systems::Cardio::Pharmacology, #AK_Step2_v11::#B&B::07_Pulmonary::02_Critical_Care::01_Shock
markdown: false

### Text
<div>
  <b>Milrinone</b> and <b>inamrinone</b> are <b>{{c1::PDE-3}}
  inhibitors</b> used in the treatment of <u>acute heart
  failure</u>
</div>

### Extra
<div>
  <i>leads to decreased breakdown of cAMP</i>
</div>
<div><img src="paste-429342110777913.jpg"></div>
<div><img src="Milrinone%20pharmacology.png"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<div><img src="paste-85959475462147.jpg"><img src=
"paste-84082574753795.jpg"><img src=
"paste-88450556493827.jpg"></div>

### Sketchy
<div>
  <i>Sketchy Pharmacology: Cardiovascular (Cardiac Glycosides)</i>
</div><img src=
"Screen%20Shot%202019-09-18%20at%209.35.05%20AM.png"> <img src=
"Screen%20Shot%202019-09-18%20at%209.35.10%20AM.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-pharmacology/units/medical-pharmacology-cardiovascular-renal/videos/medical-pharmacology-cardiovascular-and-renal-heart-failure-drugs-digoxin?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch Digoxin, milrinone, nesiritide</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/cardiology/heart-failure/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_3.png"></a>
</div>

### Additional Resources
<img src="paste-80e7c5b94581ba5f18a66b118f737fbb0860be0d.jpg">
<div><img src="big_5d7797c83364a.jpg"></div>
<div>
  <div>
    <div>
      Mechanism of action: nitrates and phosphodiesterase-5
      inhibitors
    </div>
  </div>
  <div>
    <div>
      <div>
        Exogenous nitrous oxide (NO) activates guanylyl cyclase,
        resulting in activation of protein kinase G. There is a
        reduction in intracellular calcium as a result of increased
        sarcoplasmic reticulum calcium ATPase (SERCA) and an
        increase in myosin-light-chain-phosphatase (MLCP) activity,
        resulting in smooth muscle relaxation. The net result of
        both pathways is vasodilation.
      </div>
    </div>
  </div>
</div>

### One by one

